Dow Up 0.01% Nasdaq Up 0.59%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
193.73 Up 2.71(1.42%) 11:46AM EST - Nasdaq Real Time Price
Prev Close:191.02
Open:192.55
Bid:193.45 x 500
Ask:193.62 x 100
1y Target Est:207.20
Beta:1.4
Earnings Date:Jan 28 - Feb 2 (Est.)
Day's Range:192.31 - 195.01
52wk Range:120.14 - 197.64
Volume:369,464
Avg Vol (3m):1,123,830
Market Cap:38.41B
P/E (ttm):80.59
EPS (ttm):2.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNUp 1.42%38.41B
AMGNUp 1.00%125.08B
BAXUp 0.07%39.29B

Key Statistics

Forward P/E (1 yr):32.68
P/S (ttm):18.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.20
Quarterly EPS Est (Dec-14) :1.29
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):1.23

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback